Using the immune system has also shown promise against skin cancer and some lung cancers. But for other cancers, immunotherapy is considered a last resort.

Gene immunotherapy is a new approach for cancer treatment, parts of which have begun clinical practice, and obtained prominent curative effect.

In collaboration with the Parker Institute for Cancer Immunotherapy, the first such trial is expected to launch later this year.